Macrophage Polarization Composition for Tuberculosis Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current tuberculosis treatments are inadequate in preventing the spread of the disease, as they do not effectively inhibit the survival or proliferation of Mycobacterium tuberculosis, particularly in asymptomatic individuals, and can lead to drug resistance, with existing vaccines and diagnostic methods also having limitations in stability and efficacy.

Innovation Solution

A composition that induces the polarization of macrophages into M1 macrophages using lipopolysaccharide, interferon-gamma, and inflammatory cytokines, potentially combined with anti-tuberculosis drugs, to inhibit the survival or proliferation of Mycobacterium tuberculosis by promoting apoptosis in infected macrophages.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotic therapy is used to treat tuberculosis, then the disease can be treated, but the treatment is not sufficient to prevent the spread of tuberculosis and can lead to drug resistance

Engineering Contradiction:
Improveeffectiveness of tuberculosis treatmentVSAvoiddrug resistance
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention changes the therapeutic approach from direct antibiotic killing of bacteria to modulating the immune system's macrophage polarization state. By shifting macrophages from M2 to M1 polarization through specific cytokine combinations, the treatment achieves enhanced bacterial clearance while reducing selective pressure for drug resistance

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention introduces immune modulation as an intermediary mechanism between treatment administration and bacterial elimination. Instead of antibiotics directly acting on bacteria, the treatment works through macrophage polarization as an intermediate step, which then eliminates bacteria through phagocytosis and reactive oxygen species production

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If BCG vaccination is used to induce protective immunity, then vaccination efficiency is high, but stability and efficacy are controversial

Engineering Contradiction:
Improvevaccination efficacyVSAvoidstability of vaccine
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The invention shifts from using live attenuated bacteria (BCG) to using defined cytokine combinations (IFN-γ and LPS) to achieve the desired immune effect. This chemical parameter approach provides better stability and reproducibility while maintaining the ability to induce protective M1 macrophage polarization

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If skin test with PPD is used for tuberculosis diagnosis, then exposure to Mycobacterium antigens can be detected, but sensitivity and specificity are problematic and vaccinated individuals cannot be distinguished from infected individuals

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidability to distinguish vaccinated from infected
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The invention focuses on measuring specific functional characteristics of macrophage polarization (M1 vs M2 phenotype markers) rather than general antigen reactivity. This localized measurement approach provides more precise differentiation between active infection and vaccination status by detecting the specific immune response profile associated with each condition

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS10709765B2Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same
Publication Date: 2020.07.14 THE IND & ACADEMIC COOP IN CHUNGNAM NAT UNIV (IAC)
  • US10709765B2 patent drawing
  • US10709765B2 patent drawing
  • US10709765B2 patent drawing

AI summary

The present invention provides a composition for inhibiting the survival or growth of a tubercle bacillus, containing a material which induces the polarization of a macrophage into an M1 macrophage, and a method for inhibiting the survival or growth of the tubercle bacillus by using the composition.